Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancer

Anaplastic thyroid cancer (ATC) is the most aggressive form of thyroid cancer, and novel combined therapies are urgently needed to prolong patient survival. No data are currently available on the preclinical activity of the combination of linifanib, a CSF-1R inhibitor, and irinotecan in ATC. The aim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am J Cancer Res
Hauptverfasser: Banchi, Marta, Orlandi, Paola, Gentile, Daniela, Alì, Greta, Fini, Elisabetta, Fontanini, Gabriella, Francia, Giulio, Bocci, Guido
Format: Artigo
Sprache:Inglês
Veröffentlicht: e-Century Publishing Corporation 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7407355/
https://ncbi.nlm.nih.gov/pubmed/32775005
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge